BX Swiss TOP 30 CHF
1.270,79
PKT
+9,69
PKT
+0,77
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
03.05.16 | Holcim buy | Jefferies & Company Inc. | |
03.05.16 | UBS Underperform | Merrill Lynch & Co., Inc. | |
03.05.16 | UBS buy | Citigroup Corp. | |
03.05.16 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
03.05.16 | Swiss Re overweight | JP Morgan Chase & Co. | |
03.05.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
29.04.16 | Swiss Re kaufen | DZ-Bank AG | |
28.04.16 | Richemont Outperform | Robert W. Baird & Co. Incorporated | |
28.04.16 | Novartis Neutral | UBS AG | |
27.04.16 | Nestlé Outperform | Robert W. Baird & Co. Incorporated | |
27.04.16 | Holcim Neutral | JP Morgan Chase & Co. | |
27.04.16 | UBS buy | Goldman Sachs Group Inc. | |
27.04.16 | UBS Neutral | Goldman Sachs Group Inc. | |
26.04.16 | Novartis Outperform | Bernstein Research | |
26.04.16 | Roche Outperform | Bernstein Research | |
26.04.16 | Novartis buy | HSBC | |
26.04.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
26.04.16 | ABB (Asea Brown Boveri) Underperform | BNP PARIBAS | |
26.04.16 | Novartis Neutral | BNP PARIBAS | |
25.04.16 | Holcim overweight | Morgan Stanley | |
25.04.16 | Holcim Neutral | Goldman Sachs Group Inc. | |
25.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
22.04.16 | Novartis Underweight | Morgan Stanley | |
22.04.16 | Richemont buy | UBS AG | |
22.04.16 | Holcim market-perform | Bernstein Research | |
22.04.16 | Novartis Equal weight | Barclays Capital | |
21.04.16 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
21.04.16 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
21.04.16 | Holcim Sell | Baader Wertpapierhandelsbank | |
21.04.16 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
21.04.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
21.04.16 | ABB (Asea Brown Boveri) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
21.04.16 | Holcim Hold | Kepler Cheuvreux | |
21.04.16 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
21.04.16 | UBS Neutral | UBS AG | |
20.04.16 | Roche overweight | Morgan Stanley | |
20.04.16 | ABB (Asea Brown Boveri) Halten | Independent Research GmbH | |
20.04.16 | Roche overweight | JP Morgan Chase & Co. | |
20.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
19.04.16 | Holcim Neutral | BNP PARIBAS |